Submit Manuscript  

Article Details


The Effect of Dihydroartemisinin on the Malignancy and Epithelial-Mesenchymal Transition of Gastric Cancer Cells

[ Vol. 20 , Issue. 9 ]

Author(s):

Nan Li, Suyun Zhang, Qiong Luo, Fang Yuan, Rui Feng, Xiangqi Chen* and Sheng Yang*   Pages 719 - 726 ( 8 )

Abstract:


Objective: This study aimed to observe the effects of dihydroartemisinin (DHA) on the proliferation, apoptosis, invasion, migration, and epithelial-mesenchymal transition (EMT) of the human gastric cancer cell line SGC7901 cultured in vitro.

Methods: We applied varying concentrations of DHA to SGC7901 cells. Cell proliferation was measured using the cell counting kit-8 (CCK-8). Flow cytometry, Transwell invasion assay, and cell scratch assay were used to investigate the cells’ apoptosis, invasion, and migration. Western blot was used to assess the expression levels of EMT markers E-cadhein and Vimentin, protein kinases Akt and phosphorylated AKT (p-AKT), and the cell transcription factor Snail.

Results: DHA can effectively inhibit the malignant proliferation of gastric cancer cells in a time- and dose-dependent manner. In this study, with longer incubation times and increased drug concentrations, the antiproliferation effect of DHA on SGC7901 cells increased gradually (P<0.05). In addition, with the increase of drug concentration, the expression levels of E-cadhein, an epithelial-mesenchymal transition marker, remarkably increased, whereas the protein expression levels of the mesenchymal markers Vimentin, Akt, p-Akt, and Snail significantly decreased (P<0.05).

Conclusion: DHA can effectively inhibit the proliferation, invasion, and metastasis of the gastric cancer cell line SGC7901 and induce cancer cell apoptosis. DHA can also downregulate PI3K/AKT and Snail activities and inhibit the epithelial-mesenchymal transition of gastric cancer cells. The potential anticancer effects of DHA deserve further investigation.

Keywords:

Dihydroartemisinin, gastric cancer cells, malignant behavior, epithelial-mesenchymal transition, cell counting kit-8 (CCK-8), cell invasion assay.

Affiliation:

Departments of Chinese Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001

Graphical Abstract:



Read Full-Text article